Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential

E Gorman, J Millar, D McAuley… - Expert review of …, 2021 - Taylor & Francis
Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …
被引用次数：55 相关文章

Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.

E Gorman, J Millar, D McAuley… - Expert Review of …, 2020 - europepmc.org
Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …

Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential

E Gorman, J Millar, D McAuley… - Expert Review of …, 2020 - pure.qub.ac.uk
Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …
[PDF] qub.ac.uk

[PDF][PDF] Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential

E Gorman, J Millar, D McAuley, C O'Kane - 2020 - pureadmin.qub.ac.uk
Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising therapeutic
intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and sepsis due to …
[PDF] archive.org

[PDF][PDF] Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential

E Gorman, J Millar, D McAuley, C O'Kane - 2020 - scholar.archive.org
Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising therapeutic
intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and sepsis due to …

Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential

E Gorman, J Millar, D McAuley… - Expert review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …